Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 2015

View Archived Issues

Karolinska Institute collaborates with Johnson & Johnson Innovation

Acetyl-CoA carboxylase inhibition modulates inflammation and fibrosis in the liver

Mitsubishi Tanabe participates in GHIT Fund's screening program

GIRK1 shows promise as a prognostic biomarker for ER-positive breast cancer

ID8-Fluc cells used to create clinically relevant ovarian cancer model

Novel mutation linked to FPL

Early results show gene therapy is safe in Leber's hereditary optic neuropathy trial

Novel gene therapy for Niemann-Pick disease type C

Soraphen A, a promising candidate for the treatment of HCV/HIV coinfection

FDA first to approve tiotropium bromide/olodaterol for COPD

Migalastat granted accelerated assessment by EMA for Fabry disease

FDA approves IND for COTI-2 in gynecological cancers

AbbVie completes acquisition of Pharmacyclics

Roche identifies XIAP inhibitors for cancer

Merck & Co. introduces LRRK2 inhibitors

Aurin Biotech patents complement inhibitors

Lysophospholipid S1P1 receptor ligands described in Allergan patent

Alnylam starts phase I trial of ALN-AS1 in patients with acute intermittent porphyria

Bristol-Myers Squibb patent reports GSK-3 inhibitors

Intellipharmaceutics' Rexista receives fast track designation

Cymbalta approved in Japan for fibromyalgia pain

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

Synageva BioPharma files NDA for sebelipase alfa in Japan

European Commission approves Aloxi for pediatric use

FDA permits sale of Roche's Clostridium difficile diagnostic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...